These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 25808512)

  • 1. Valproate-induced enuresis: a prospective study.
    Yamak WR; Hmaimess G; Makke Y; Sabbagh S; Arabi M; Beydoun A; Nasreddine W
    Dev Med Child Neurol; 2015 Aug; 57(8):737-41. PubMed ID: 25808512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium valproate induced increased frequency of micturition and enuresis.
    Gosavi DD; Suman A; Jain M
    Indian J Pharmacol; 2013; 45(1):87-8. PubMed ID: 23543036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sleep Architecture in Valproate-Induced Nocturnal Enuresis in Primary School and Preschool Children.
    Esmael A; Elsherief M; Abdelsalam M; Bendary L; Egila H
    J Child Neurol; 2020 Dec; 35(14):975-982. PubMed ID: 32762394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An observational study of first-line valproate monotherapy in focal epilepsy.
    Jedrzejczak J; Kuncíková M; Magureanu S;
    Eur J Neurol; 2008 Jan; 15(1):66-72. PubMed ID: 18042239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical observation of valproate sodium-induced nocturnal enuresis].
    Yokoyama A; Saito Y; Maegaki Y; Ohno K
    No To Hattatsu; 2007 May; 39(3):227-8. PubMed ID: 17515140
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of subclinical hypothyroidism in ambulatory children with controlled epilepsy on valproate monotherapy.
    Sahu JK; Gulati S; Kabra M; Arya R; Sharma R; Gupta N; Kaleekal T; Reeta Kh; Gupta YK
    J Child Neurol; 2012 May; 27(5):594-7. PubMed ID: 22114214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversible valproate-induced choreiform movements.
    Gunal DI; Guleryuz M; Bingol CA
    Seizure; 2002 Apr; 11(3):205-6. PubMed ID: 12018966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valproate-associated coagulopathies in children during short-term treatment.
    Köse G; Arhan E; Unal B; Ozaydin E; Guven A; Sayli TR
    J Child Neurol; 2009 Dec; 24(12):1493-8. PubMed ID: 19482838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of bone mineral density in children receiving carbamazepine or valproate monotherapy.
    Chou IJ; Lin KL; Wang HS; Wang CJ
    Acta Paediatr Taiwan; 2007; 48(6):317-22. PubMed ID: 18437965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valproic acid-induced nocturnal enuresis in pediatric patients.
    Ozan K; Coskun Y; Bora CK; Ayten Y
    Niger J Clin Pract; 2019 Jan; 22(1):108-112. PubMed ID: 30666028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of rapid intravenous valproate infusion in pediatric patients.
    Morton LD; O'Hara KA; Coots BP; Pellock JM
    Pediatr Neurol; 2007 Feb; 36(2):81-3. PubMed ID: 17275657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High incidence of vaproate-induced coagulation disorders in children receiving valproic acid: a prospective study.
    Koenig S; Gerstner T; Keller A; Teich M; Longin E; Dempfle CE
    Blood Coagul Fibrinolysis; 2008 Jul; 19(5):375-82. PubMed ID: 18600085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fanconi syndrome caused by sodium valproate: report of three severely disabled children.
    Yoshikawa H; Watanabe T; Abe T
    Eur J Paediatr Neurol; 2002; 6(3):165-7. PubMed ID: 12363104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early cognitive development in children born to women with epilepsy: a prospective report.
    Bromley RL; Mawer G; Love J; Kelly J; Purdy L; McEwan L; Briggs M; Clayton-Smith J; Shi X; Baker GA;
    Epilepsia; 2010 Oct; 51(10):2058-65. PubMed ID: 20633039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weight gain in children treated with valproate.
    Sharpe C; Wolfson T; Trauner DA
    J Child Neurol; 2009 Mar; 24(3):338-41. PubMed ID: 19258293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of valproate therapy on thrombin generation determined by calibrated automated thrombography.
    Topf HG; Lischetzki G; Trollmann R; Rascher W; Rauh M
    Klin Padiatr; 2011 May; 223(3):165-8. PubMed ID: 21472635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Influence of age, body weight and dose on sodium valproate plasma concentrations in children with epilepsy].
    Jiang Z; Zhang J; Liao HM; Tang JW; Peng QL
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Jun; 10(3):325-8. PubMed ID: 18554460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma free carnitine in epilepsy children, adolescents and young adults treated with old and new antiepileptic drugs with or without ketogenic diet.
    Coppola G; Epifanio G; Auricchio G; Federico RR; Resicato G; Pascotto A
    Brain Dev; 2006 Jul; 28(6):358-65. PubMed ID: 16376041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Craniosynostosis and fetal exposure to sodium valproate.
    Lajeunie E; Barcik U; Thorne JA; El Ghouzzi V; Bourgeois M; Renier D
    J Neurosurg; 2001 Nov; 95(5):778-82. PubMed ID: 11702867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the abrupt switch from solution to modified-release granule formulation of valproate.
    Verrotti A; Nanni G; Agostinelli S; Alleva ET; Aloisi P; Franzoni E; Spalice A; Chiarelli F; Coppola G
    Acta Neurol Scand; 2012 Mar; 125(3):e14-8. PubMed ID: 21707552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.